Intrepid Financial Planning Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,661
Closed -$304K 134
2025
Q2
$304K Hold
3,661
0.13% 96
2025
Q1
$297K Sell
3,661
-350
-9% -$31.3K 0.14% 92
2024
Q4
$361K Sell
4,011
-410
-9% -$39.7K 0.15% 87
2024
Q3
$437K Sell
4,421
-220
-5% -$21.6K 0.19% 76
2024
Q2
$430K Hold
4,641
0.18% 78
2024
Q1
$440K Sell
4,641
-375
-7% -$34.8K 0.19% 79
2023
Q4
$448K Sell
5,016
-50
-1% -$3.71K 0.21% 72
2023
Q3
$370K Hold
5,066
0.19% 74
2023
Q2
$421K Sell
5,066
-60
-1% -$5.02K 0.2% 73
2023
Q1
$391K Sell
5,126
-68
-1% -$5.64K 0.2% 72
2022
Q4
$431K Sell
5,194
-563
-10% -$45.6K 0.23% 65
2022
Q3
$457K Buy
5,757
+10
+0.2% +$843 0.26% 57
2022
Q2
$427K Buy
+5,747
New +$431K 0.23% 60

Other funds holding XBI